Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Product List
Intermediates CAS No.
Abiraterone intermediates
-hydroxy-androst-5-ene-17-hydrazone 63015-10-1
17-Iodoandrosta-5,16-dien-3beta-ol 32138-69-5
diethyl-(pyridin-3-yl)-borane 89878-14-8
-hydroxy-17-iodo-androsta-5,16-diene 32138-69-5
Acitretin Intermediates
4-Methoxy-2,3,6-trimethyl-benzaldehyde 54344-92-2
(3E)-4-(4-methoxy-2,3,6-trimethylphenyl)but-3-en-2-one 62924-31-6
Acotiamide Intermediates
N-(2-(Diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-
1,3-thiazole-4-carboxyamide
185106-16-5
2-Hydroxy-4,5-dimethoxybenzoic acid 5722-93-0
2-Aminothiazole-4-carboxylic acid 40283-41-8
N1,N1-diisopropylethane-1,2-diamine 14165-22-1
N-Ethyl-N-isopropylpropan-2-amine 7087-68-5
Adefovir Dipivoxil Intermediates
PMEA 106941-25-7
Afatinib Intermediates
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro 162012-67-1
Acetic acid,2-(diethoxyphosphinyl) 3095-95-2
Ethanamine,2,2-diethoxy-N,N-dimethyl 3616-56-6
Agomelatine
7-Methoxy-1-naphthylacetonitrile 138113-08-3
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
7-Methoxy-1-Tetralone 6836-19-7
Alogliptin Intermediates
(R)-3-Boc-aminopiperidine 309956-78-3
2- [(6-C hloro-3,4-dihydro-3-m ethyl-2,4-dioxo-1(2H)-
pyrimidinypmethyllbenzonitrile
865758-96-9
(R)-3-Piperidinamine dihydrochloride 334618-23-4
6-Chloro-3-methyluracil 4318-56-3
2-Cyanobenzyl bromide 22115-41-9
Alosetron Hydrochloride Intermediates
2,3,4,5-Tetrahydro-5-methyl-1H-pyrido[4,3-b]indol-1-one 122852-75-9
Almotriptan Intermediates
4-chlorobutyraldehyde diethy acetal 6139-83-9
1-((4-Aminobenzenemethane)sulfonyl)pyrrolidine 334981-10-1
4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride 334981-11-2
Allopurinol Intermediate
3-Amino-Pyrazole-4-Carboxamide Hemisulfate 27511-79-1
Ambrisentan Intermediates
4,6-Dimethyl-2-methylsulfonylpyrimidine 35144-22-0
Amprenavir Intermediates
(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-
Phenylbutane
98737-29-2
(3S)-3-(tert-Butoxycarbonyl)amino-1-
chloro-4-phenyl-2-butanone
102123-74-0
(1S,2S)-(1-Benzyl-3-chloro-2-
hydroxypropyl)carbamic acid tert-butyl
ester
165727-45-7
Anagliptin
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
2-Methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid 739364-95-5
2-Methyl-1,2-propanediamine 811-93-8
Apixaban Intermediates
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate 27143-07-3
5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-
pyridinone
545445-44-1
1-(4-Methoxypheny1)-7-oxo-6-[4-(2-oxopiperid in-l-yOphenyl]-4,5,6,7-
tetrahydro-11-1-pyrazolo[3,4-c]pyridine-3-carboxylie acid ethyl ester
503614-91-3
Arobicin Intermediates
2-Amino-1,2,3,4-tetrahydro-5,8-dimethoxy-2-naphthalenecarboxylic acid 99907-84-3
Amrubicin 110267-81-7
Atazanavir Intermediates
(2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-
epoxy-4- phenylbutane
98760-08-8
Moc-L-tert-Leucine 162537-11-3
L-tert-Leucine 20859-02-3
2-[[4-(2-Pyridinyl)phenyl]methyl]-
hydrazinecarboxylic acid 1,1-dimethylethyl
ester
198904-85-7
2-[[4-(2-Pyridinyl) phenyl] methyl]-
hydrazinecarboxylic acid 1, 1-dimethylethyl
ester
127406-56-8
Atorvastatin Calcium Intermediates
Ats-4 86728-85-0
Ats-5 141942-85-0
Ats-8 125971-94-0
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Ats-9 125995-13-3
M-3 125971-57-5
M-4 125971-96-2
Axitinib Intermediates
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-
indazole
886230-77-9
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-
amine
886230-76-8
2-mercapto-N-methylbenzamide 20054-45-9
Azelnidipine Intermediates
2-(3-nitrobenzylidene)acetoacetate Isopropyl 39562-25-9
1-Diphenylmethyl-3-hydroxyazetidine 1862-17-5
1-benzhydrylazetidine-3-carbonitrile 36476-86-5
3-amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester acetate 170749-59-4
Azilsartan Intermediates
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-
3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, Methyl ester
147403-52-9
Bataxolol Intermediates
(Bromomethyl)cyclopropane 7051-34-5
Biapenem Intermediates
6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloride 153851-71-9
Bortezomib Intermediates
(aR)-(1S,2S,3R,5S)-Pinanedio1-1-amino-3-methylbutane-l-boronate
Trifluoroacetate
179324-87-9
Bortezomibpinanediol ester 205393-22-2
Bosutinib Intermediates
4-Chloro-3-cyano-7-hydroxy-6-methoxyquinoline 263149-10-6
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
4-Chloro-7-fluoro-6-methoxy-3-quinolinecarbonitrile 622369-40-8
4-Chloro-7-(3-chloropropoxy)-3-cyano-6-methoxyquinoline 214470-68-5
3-Quinolinecarbonitrile,4-chloro-6-Methoxy-743-(4-Methyl-l-
piperazinyl)propoxy]
492444-39-0
Brinzolamide Internediates
3-Acetyl-2,5-dichlorothiophene 36157-40-1
3-(Bromoacetyl)-5-chloro-2-thiophenesulfonamide 160982-11-6
(S)-3,4-Dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide 160982-16-1
(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-
thiazine-6-sulfonamide 1,1-dioxide
154127-42-1
Candesartan Cilexetil Intermediates
Ethyl-2-t-butoxy-2-carboxylamino-3-nitrobenzoate 136285-65-9
Ethyl-2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl] benzimidazole-7-
carboxylate
139481-41-7
Methyl-2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl] benzimidazole-7-
carboxylate
139481-44-0
Ethyl-2-ethoxy-1-[[(2'-(1Htetrazol-5-yl)biphenyl-4-yl-)methyl]benzimidazole-
7-carboxylate
139481-58-6
2-ethoxy-1-[[(2'-(1Htetrazol-5-yl)biphenyl-4-yl-)methyl] benzimidazole-7-
carboxylic acid
139481-59-7
Trityl Candesartan 139481-72-4
Trityl Candesartan Cilexetil 170791-09-0
Cyclohexyl-(1-chloroethyl)-carbonate 99464-83-2
Canagliflozin Intermediates
2-(4-Fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene 898566-17-1
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene 1030825-20-7
5-Bromo-2-chlorobenzoic acid 79669-49-1
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone 32384-65-9
2-(4-Fluorophenyl)thiophene 58861-48-6
(5-bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]- Methanone 1132832-75-7
Capecitabine Intermediates
1,2,3-triacetyl-5-deoxy- -D-Riboturanose 62211-93-2
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine 161599-46-8
Carfilzomib Intermediates
Morpholin-4-ylacetic acid 3235-69-6
(alphaS)-alpha-Am inobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester
mono (trifluoroacetate)
868539-99-5
[(1S)-3-Methy1-1-[[(2R)-2-methyloxiranyl]carbonylibutyl]carbamicacid 1,1-
dim ethylethyl ester
247068-82-2
(2S)-2-Amino-4-methy1-1-[(2R)-2-methyloxirany1]-1-pentanone
trifluoroacetate
247068-85-5
875309-83-4
Cefditoren Pivoxil Intermediates
4-Methyl-5-fomylthiazole 82294-70-0
Ceritinib Intermediates
5-Methyl-2-(1-methylethoxy)-4-(4-piperidinyl)benzenamine hydrochloride 1380575-45-0
4-Pyrimidinamine, 2,5-dichloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]- 761440-16-8
Crizotinib Intermediates
3-[(1R)-(2,6- dichloro -3-fluorophenyl) ethoxy]-2- amino -5- bromopyridin 877399-00-3
1-(N-Boc-piperidine-4-ly)-boronic acid pinacol ester 877399-74-1
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Dabigatran Etexilate Intermediates
3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-
PROPIONIC ACID ETHYL ESTER
212322-56-0
N-(4-Cyano-phenyl)-glycine 42288-26-6
Hexyl chloroformate 6092-54-2
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-
yl]carbonyl] pyridin-2-ylamino]propionic acid ethyl ester
211915-84-3
Daclatasvir Intermediates
(1aR,12bS)-8-Cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-
methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-
tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide
1235403-62-9
(2S,2'S)-di-tert-butyl 2,2'-(4,4'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-iMidazole-4,2-
diyl))bis(pyrrolidine-1-carboxylate)
1007882-23-6
Dapagliflozin Intermediates
5-bromo-2-chlorobenzoic acid 21739-92-4
5-bromo-2-chloro-4'-ethoxydiphenylmethane 461432-23-5
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl) methanone 461432-22-4
Darifenacin Intermediates
2,3-Dihydrobenzofuranyl-5-acetic acid 69999-16-2
5-(2-Bromoethyl)-2,3-dihydrobenzofuran 127264-14-6
(S)-3-Hydroxypyrrolidine hydrochloride 122536-94-1
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate 134002-26-9
Darunavir Intermediates
(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-
Phenylbutane
98737-29-2
(3S)-3-(tert-Butoxycarbonyl)amino-1-
chloro-4-phenyl-2-butanone
102123-74-0
(1S,2S)-(1-Benzyl-3-chloro-2-
hydroxypropyl)carbamic acid tert-butyl
ester
165727-45-7
Dasatinib Intermediates
2-amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5
Deferasirox Intermediates
4-Hydrazinylbenzoic acid 619-67-0
2-Hydroxybenzamide 65-45-2
Delafloxacin intermediates
1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-[3-( 2-
methyl-1-oxopropoxy)-1-azetidinyl]-4-oxo-, ethyl ester
875712-90-6
1-(6-amino-3,5-difluoro-2-pyridinyl)-6-fluoro-1,4-dihydro-7-[3-(2-methyl- 1-
oxopropoxy)-1-azetidinyl]-4-oxo-, ethyl ester
442526-91-2
Benzenepropanoic acid, -[[(6-amino-3,5-difluoro-2-pyridinyl)amino]
methylene]-2,4,5-trifluoro- -oxo-, ethyl ester
875712-88-2
2,6-Diamino-3,5-difluoropyridine 247069-27-8
Dolutegravir Intermediates
1-(2,2-DiMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)- 1335210-23-5
4-Oxo-1,4-Dihydropyridine-3-Carboxylic Acid3-(Benzyloxy)-4-Oxo-4H-Pyran-
2-Carboxylic Acid
1206102-08-0
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Dimethyl 3-(Benzyloxy)-4-Oxo-4H-Pyran-2,5-Dicarboxylate 1246616-66-9
Donepezil HCL Intermediates
5,6-dimethoxy-1-indanone 2107-69-9
4-pyridine carboxaldehyde 872-85-5
1-Benzyl-4-Piperidine carboxaldehyde 22065-85-6
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)-piperidine 120014-07-5
2,3-dihydro-5,6-dimethoxy-2-((piperidin-4-yl)methyl)inden-1-one HCL 120013-39-0
5,6-dimethoxy-2-(4-pyridylmethylene)-1-Indanone 4803-74-1
Donepezil Base 120014-06-4
Doripenem Intermediates
ACS-PNZ-PYRROLIDYL-(BOC)-NSO2NH2 491878-06-9
Dorzolamide Intermediates
2-Mercaptothiophene 7774-74-5
(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 147086-79-1
6-Methyl-4-oxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 120279-88-1
(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide 148719-91-9
(4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide 147128-77-6
N-[(4S,6S)-6-Methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-
b]thiopyran-4-yl]acetamide
147200-03-1
Efavirenz Intermediates
Cyclopropyl Acetylene 6746-94-7
Cyclopropyl Methyl Ketone 765-43-5
Eldecalcitol Intermediates
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
[(2Z)-2-[(3R,4R,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-[[(1,1-
di Methylethyl)di Methylsilyl]oxy]propoxy]-2-
Methylenecyclohexylidene]ethyl]diphenyl-
200636-54-0
Empagliflozin Intermediates
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran 915095-94-2
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone 32384-65-9
(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan 915095-89-5
Entecavir Intermediates
(1R,2S)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol 188399-48-6
(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-
methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-
((benzyloxy)methyl)cyclopentanol
142217-78-5
6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-
methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-
amine
142217-80-9
2-Amino-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-
methylenecyclopentyl)-1H-purin-6(9H)-one
142217-81-0
Erlotinib Intermediates
6,7-bis-(2-methoxyethoxy)-4(3H)-quinazolinone 179688-29-0
4,5-bis-(2-methoxyethoxy)-2-nitrobenzonitrile 236750-65-5
4-chloro-6,7-bis-(2-methoxyethoxy)-4(3H)-quinazolinone 183322-18-1
Febuxostat Intermediates
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate 161797-99-5
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Ethyl 2-(3-formy1-4-hydroxypheny1)- 4-methylthiazole-5-carboxylate 161798-01-2
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate 161798-03-4
Ethyl 2-(3-cyano-4-isobutoxypheny1)-4-methyl-5-thiazolecarboxylate 160844-75-7
Fosamprenavir Intermediates
(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4- Phenylbutane 98737-29-2
(3S)-3-(tert-Butoxycarbonyl)amino-1-
chloro-4-phenyl-2-butanone
102123-74-0
(1S,2S)-(1-Benzyl-3-chloro-2-
hydroxypropyl)carbamic acid tert-butyl
ester
165727-45-7
Fulvestrant Intermediates 7 ,17 -7-[9-(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estra- 1,3,5(10)- triene-
3-diol -17oxyethyl
875573-69-6
4,4,5,5,5-Pentafluoro-1-pentanethiol 148757-88-4
Gefitinib Intermediates
6-acetoxy-4-(3'-chloro-4'-fluoroanilino)-7-methoxyquinazoline 788136-89-0
2-nitro-4-methoxy-5-(3-chloropropoxy)benzonitrile 1315512-61-8
3,4-dihydro-7-methoxy-4-oxo-quinazolin-6-yl acetate 179688-53-0
4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol 184475-71-6
6-hydroxy-7-methoxy-3H-quinazolin-4-one 179688-52-9
7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one 199327-61-2
Gemcitabine Intermediates
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate 122111-01-7
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Ethyl (3R,S)-2,2-difluoro-3hydorxy-3-(2,2-
dimethlydioxolan-yl)propionate
95058-92-7
Glimepiride
3-ethyl-4-methyl-3-pyrroline-2-one 766-36-9
4-[2-(3-ethyl-4-methyl-2-oxo-pyrroline-1-carboxamido)-ethyl]] Benzene
sulfonamide
119018-29-0
Trans-4-methyl cyclohexyl amine 2523-55-9
Trans-4-methyl cyclohexyl isocyanate 32175-00-1
Glipizide Intermediates
5-Methylpyrazine-2-carboxylic acid 5521-55-1
Irbesartan Intermediates
2n-Butyl-1.3-Diazaspiro[4.4]non-1-en-4-one·HCl 151257-01-1
[1.1' -Biphenyl]-2-carbonitrile-4-[(2-butyl-4 -oxo-1.3- diazaspiro[4.4]non-1-en-
3-yl)methyl]
138401-24-8
Trityl Irbesartan 138402-10-5
Ibrutinib Intermediates
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-
amine
1022150-12-4
4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 330786-24-8
Imatinib Intermediates
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride 106261-49-8
Indacaterol Intermediates
5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone 173140-90-4
8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline 100331-89-3
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride 312753-53-0
Intedanib Intermediates(NEW)
Methyl 2-oxoindole-6-carboxylate 14192-26-8
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
n-(4-aminopheny1)-n,4-dimethy1-1-piperazineacetamide 262368-30-9
Isavuconazole Intermediates
4-(2-Bromoacetyl)benzonitrile 20099-89-2
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-
yl)thiobutyraMide
368421-58-3
1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone 1157938-97-0
LCZ-696 Intermediates
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-
Methylpentanoic acid
1012341-50-2
AHU-377 149709-62-6
Levetiracetam Intermediates
(S)-2-Aminobutanamide hydrochloride 7682-20-4
Ledipasvir Intermediates
2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-
yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)-
1256387-74-2
(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-
benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-
dimethylethyl ester
1256387-87-7
Lenalidomide Intermediates
Methyl 2-bromomethyl-3-nitrobenzoate 98475-07-1
2,6-Dioxopiperidine-3-ammonium chloride 24666-56-6
Lesinurad Intermediates
4-cyclopropylnaphthalen-1-aMine hydrochloride 1533519-92-4
4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione 1533519-84-4
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
5-Amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol 878671-96-6
Linagliptin Intermediates
1-Bromo-2-Butyne 3355-28-0
(R)-3-(Boc-Amino)piperidine 309956-78-3
(R)-3-Piperidinamine dihydrochloride 334618-23-4
3-Methylxanthine 1076-22-8
8-Bromo-3-methyl-xanthine 93703-24-3
2-(chloromethyl)-4-methylquinazoline 109113-72-6
8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione 666816-98-4
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-
quinazolinyl)methyl]-1H-purine-2,6-dione
853029-57-9
Lorcaserin Hydrochloride Intermediates
1-[ [ 2-(4-Chlorophenyl)ethyl] amino] -2-chlo
ropropane Hydrochloride
953789-37-2
Loxoprofen sodium Intermediates
Loxoprofen; 2-(4-((2-oxocyclopentyl)methyl)phenyl)propanoic acid 68767-14-6
Methyl 2-Cyclopentanone carboxylate 10472-24-9
2-(4-Bromomethyl)phenylpropionic acid 111128-12-2
Lurasidone Intermediates
(1R,2R)-1,2-Cyclohexanedicarboxylic acid 46022-05-3
(1R,2R)-1,2-Cyclohexanedimethanol 65376-05-8
3-(1-Piperazinyl)-1,2-benzisothiazole 87691-87-0
(1S,2S)-Cyclohexane-1,2-dimethanol 3205-34-3
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
(R,R)-1,2-Bis(methanesulfonylloxy methyl) cyclohexane 186204-35-3
(3AR,4S,7R,7AS)4,7-Methano-1H-isoindole-1,3-(2H)-dione 14805-29-9
1-(1,2-Benzisothiazol-3-yl)piperazine hydrochloride 87691-88-1
Macitentan Intermediates
N-Propylsulfamide 147962-41-2
4,6-Dichloro-5-(4-bromophenyl)pyrimidine 146533-41-7
Memantine HCL
1-Bromo-3,5-dimethyladamantane 941-37-7
1 ,3-dimethyl adamantane 702-79-4
Methylphenidate HCl Intermediates
2-Phenyl-2-(2-piperidyl)acetic acid 19395-41-6
Moxifloxacin Intermediates
(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-
b]pyridine
151213-40-0
Netupitant Intermediates
N-Methy1-4-(2-methylpheny1)-6-(4-methyl-1-piperaziny1)-3-pyridinamine 290297-25-5
2-(3,5-Bis(trifluoromethyl)pheny1)-2-methylpropionic acid 289686-70-0
Nintedanib Intermediates
Methyl oxindole-6-carboxylate 14192-26-8
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide 262368-30-9
Obeticholic Acid Intermediates
6-Ethylchenodeoxycholic acid 459789-99-2
7-ketolithocholic Methyl ester 10538-59-7
(E)- -hydroxy-6-ethylidene-7-keto- -cholan-24-oic acid 1516887-33-4
3-alpha-Hydroxy-7-oxo-5-beta-cholanic acid 4651-67-6
Olaparib Intermediates
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-
fluorobenzyl)phthalazin-1(2H)-one
763113-22-0
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid 763114-26-7
1-(Cyclopropylcarbonyl)piperazine hydrochloride 1021298-67-8
Olmesartan Medoxomil Intermediates
4-chloromethyl-5-methyl-1 ,3-dioxol-2-one 80841-78-7
Ethyl-4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-Carboxylate 144689-93-0
Trityl Olmesartan Ethyl Ester 189400-21-3
Trityl Olmesartan 761404-85-7
Trityl Olmesartan Medoxomil 144690-92-6
Olopatadine Intermediates
Isoxepac 55453-87-7
Oxybutynin HCl Intermediates
Oxybutynin Base 5633-20-5
a-Cyclohexyl-Mandelic acid Methyl ester 10399-13-0
4-(diethylamino)but-2-ynyl Aceate 22396-77-6
Palbociclib Intermediates
6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one 1016636-76-2
4-(6-aminopyridin-3-yl)piperazine-1-carboxylic 571188-59-5
Paliperidone Intermediates
6,7,8,9-Tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-
piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-one
144598-75-4
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride 84163-13-3
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-
a]pyrimidin-4-one
130049-82-0
Palonosetron Hydrochloride Intermediates
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid 85977-52-2
(S)-3-Aminoquinuclidine dihydrochloride 119904-90-4
Pantoprazole Intermediates
2-Chloromethyl-3,4-Dimethoxy Pyridine HCl 72830-09-2
5-Difluoromethoxy-2-Mercapto-1H-Benzimidazole 97963-62-7
5-Difluoromethoxy-2-{[(3,4-Dimethoxy-2-Pyridinyl)Methyl]thio}-1H-
Benzimidazole
102625-64-9
Phenylephrine Intermediates
3-Hydroxy Acetophenone 121-71-1
-(N-Benzyl-N-Methylamino)-m-Hydroxy-Acetophenone HCl 71786-67-9
Pimobendan Intermediates
6-(3,4-Diaminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone 74150-02-0
Benzamide,N-[2-amino-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-
pyridazinyl)phenyl]-4-methoxy-
74149-74-9
Pitavastatin Calcium
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-
5-oxo-6-triphenylphosphoranylidene
hexanate
147118-35-2
Prasugrel
1-Cyclopropyl-2-(2-fluorophenyl)ethanone 150322-73-9
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone 204205-33-4
Thie[3,2-c]pyridin-2(4H)-one,5,6,7,7a-tetrahydro hydrochloride 115473-15-9
Posaconazole Intermediates
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
5-(2,4-Difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-
ylmethyl ester
149809-43-8
2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-
1-piperazinyl]phenyl]- 3H-1,2,4-triazol-3-one
184177-83-1
Raloxifene Intermediates
2-(4-Hydroxyphenyl)benzo[b]thiophene-6-ol 63676-22-2
Rasagiline Intermediates
Propargyl benzenesulfonate 6165-75-9
Rebamipide Intermediates
2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid(H2O.HCL) 5162-90-3
2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid(2H20.2HCL) 5162-90-3
4-Bromomethyl-1,2-Dihydroquinoline-2-One 4876-10-2
Diethyl [(4-Chlorobenzoyl)Amino]Propanedioate 81918-01-6
Diethyl2-(4-Chlorobenzamido)-2-[(2-Oxo-1,2-Dihydroquinolin-4-
yl)Methyl]malonate
1028268-32-7
Regorafenib Intermediates
4-Amino-3-fluorophenol 399-95-1
4-Chloro-3-(trifluoromethyl)phenyl isocyanate 327-78-6
N-methyl-4-chloropicolinamide 220000-87-3
Rimonabant Intermediates
2-Bromo-2',4'-dichloroacetophenone 2631-72-3
Rivastigmine tartrate
N-Ethyl-N-Methyl Carbamoyl Chloride 42252-34-6
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
(S)-3-1(- Dimethylamino)ethylphenol 139306-10-8
Rivaroxaban Intermediates
5-Chlorothiophene-2-carboxylic acid 24065-33-6
4-(4-Aminophenyl)morpholin-3-one 438056-69-0
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide 161596-47-0
1H-Isoindole-1,3(2H)-dione,2-[[(5S)-2-oxo
-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxaz olidinyl]methyl
446292-08-6
(4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl
)amino)phenyl]morpholin-3-one )
1252018-10-2
4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazo lidinyl]phenyl]-3-morpholinone
hydrochloride
898543-06-1
1H-Isoindole-1,3(2H)-dione,2-[(2R)-2-hydr oxy-3-[[4-(3-oxo-4-
morpholinyl)phenyl]ami
no]propyl]-
446292-07-5
Rizatriptan Intermediates
4-Dimethylamino butyaldehyde dimethylacetal 19718-92-4
1-(4-HYDRAZINOBENZYL)-1H-1,2,4-TRIAZOLE 144035-22-3
Rocuronium Intermediates
(2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol 119302-20-4
2a,3a-Epoxy-16b-(1-pyrrolidinyl)-5a-androstan-17b-ol 119302-19-1
2a,3a,16a,17a-Diepoxy-17b-acetoxy-5a-androstane 50588-22-2
Rosuvastatin Calcium Intermediates
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Rosuvastatin Calcium C-4 1540426-95-6
Rosuvastatin Calcium C-5 124655-09-0
Rosuvastatin Calcium C-6 124752-23-4
Rosuvastatin Calcium Z-7 147118-36-3
4-(4-Fluorophenyl)-6-Isopropyl-2- [(N-
Methyl-N-Methylsulfonyl) amino]-5-
Formylpirimidine
147118-37-4
Methyl(3R)-(tert-butyldimethylsilyloxy)-5-
oxo-6-
triphenylphosphoranylidenehexanoate
147118-39-6
Rosuvastatin Methyl Ester 147118-40-9
tert-Butyl rosuvastatin 355806-00-7
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-
5-oxo-6-triphenylphosphoranylidene
hexanate
147118-35-2
Saquinavir Intermediates
(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-
Phenylbutane
98737-29-2
(3S)-3-(tert-Butoxycarbonyl)amino-1-
chloro-4-phenyl-2-butanone
102123-74-0
(1S,2S)-(1-Benzyl-3-chloro-2-
hydroxypropyl)carbamic acid tert-butyl
ester
165727-45-7
Saxaliptin Intermediates
(1S,3S,5S)-3-(Aminocarbonyl)-2-
azabicyclo[3.1.0]hexane-2-carboxylic acid
tert-butyl ester
361440-67-7
(alphaS)-alpha-Amino-3-
hydroxytricyclo[3.3.1.13,7]decane-1-acetic
acid
709031-29-8
/361442-00-4(HCl)
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Boc-3-Hydroxy-1-adamantyl-D-glycine 361442-00-4
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide monomethanesulfonate 709031-45-8
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride 709031-39-0
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid
tert-butyl ester
361440-67-7
Silodosin Intermediates
1-[3-(benzyloxy)propy1]-5-formylindoline-7-carbonitrile 1375180-30-5
5-[(2R)-2-Aminopropy1]-1[3-(benzoyloxy)propy1]-2,3-dihydro-1H-indole-7-
carbonitrile (2R,3R)-2,3 -dihydroxybutanedioate
239463-85-5
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate 160969-03-9
Sofosbuvir Intermediates
L-Alanine isopropyl ester hydrochloride 62062-65-1
GS-7977 1190307-88-0
2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine 863329-66-2
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-
Methylethyl ester
1334513-02-8
Solifenacin Intermediates
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline 118864-75-8
(R)-(-)-3-Quinuclidinol 25333-42-0
3-Quinuclidinone hydrochloride 1193-65-3
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Sumatriptan Succinate Intermediates
4-chlorobutyraldehyde dimethyl acetal 29882-07-3
4-Hydrazino-N-Methylbenzenemethanesulfonamide Monohydrochloride 88933-16-8
Sunitinib Intermediates
5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid 253870-02-9
Telmisartan Intermediates Methyl ’-bromomethyl biphenyl-2-carboxylate 114772-38-2
2-n-Propyl-4-methyl-6-(1-methylbenzi midazole-2-ly) benzimidazole 152628-02-9
Teneligliptin Intermediates
(2S)-4-oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidine carboxylicacid tert-butyl
ester
401564-36-1
1-(3-methyl-1-phenyl-1H-pyrazole-5-yl) piprazine 401566-79-8
Ticagrelor Intermediates
(1R,2S)-2-(3,4-
Difluorophenyl)cyclopropanamine
220352-38-5
(1R,2S)-2-(3,4-
Difluorophenyl)cyclopropanaminium (2R)-
hydroxy(phenyl)ethanoate
376608-71-8
2-((3aR,4S,6R,6aS)-6-amino-2,2-
dimethyltetrahydro-3aH-
cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-
tataric acid
376608-65-02
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 145783-15-9
Torasemide
4-Hydroxypyridien 626-64-2
4-(3-methylphenyl) amino-3-pyridine sulfonamide 72811-73-5
Trelagliptin Intermediates
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
2-Cyano-5-Fluorobenzyl Bromide 421552-12-7
6-chlorouracil-3-Methyl 4318-56-3
Valsartan Intermediates
N-[[(2' -cyano(1.1' -biphenyl)-4-yl)methyl] methyl ester]-L -valine·HCl 482577-59-3
Trityl Valsartan 195435-23-5
Valsartan Methyl ester 137863-17-3
Vilazodone Intermediates
Ethyl 5-nitrobenzofuran-2-carboxylate 69604-00-8
5-aminobenzofuran-2-carboxylic acid 42933-44-8
3-(4-Chlorbutyl)-1H-indol-5-carbonitril 143612-79-7
5-(1-piperazinyl)benzofuran-2-carboxamide 183288-46-2
5-Cyanoindole 15861-24-2
Vildagliptin Intermediates
L-Prolinamide 7531-52-4
3-Amino-1-adamantanol 702-82-9
(2S)-1-chloroacetyl-2-pyrrolidine carbonitrile 207557-35-5
Vonoprazan fumarate Intermediates
TAK-438 1260141-27-2
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde 881674-56-2
1H-Pyrrole-3-carboxylic acid, 5-(2-fluorophenyl)-, ethyl ester 881674-06-2
Vortioxetine Intermediates
4-(2-BROMO-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER 494773-35-2
1-BOC-PIPERAZINE 57260-72-7
APIs
Intermediates
Regulatory Affairs
Finished Formulations
No 55, Ground Floor, 8th Main, J. P. Nagar 3rd Phase, Bangalore 560 078 – INDIA Tel: +91 80 41536439,
Mobile: +91 98452 86404 Fax: +91 80 2649 1872, e-mail: [email protected], web site: www.cadpharma.com
CAD Pharma Inc.
Zolmitriptan Intermediates
4-Dimethylamino butyaldehyde diethyl acetal 1116-77-4
(4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one 139264-17-8
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone 152305-23-2
Zopiclone Intermediates
4-methyl-1-piperazinecarbonyl chloride
hydrochloride
55112-42-0